Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention

Summary

The aim of this study is to evaluate the effects of N-acetyl cysteine on major cardiac and cerebral events in patients undergoing primary percutaneous coronary intervention who have moderate to high risk for contrast induced nephropathy. In a sub-group of patients coronary flow reserve will be evaluated.

Timeline

Start

2013-01

Primary completion

2018-01

Completion

2026-12

Drugs

Indications